News

As part of the deal, Abbott will acquire Garden Hills, which currently owns more than 80% of Veropharm, for about $395m or $495m, depending on Garden Hills’ share

The company said that BNC375 and related compounds have displayed potent efficacy in animal cognitive impairment models. As part of the deal, Merck will provide funding for all

ILUVIEN (190 micrograms intravitreal implant in applicator) has been designated a C Class product in Italy and it will be available initially to private paying patients. The company

The EMA orphan drug status provides a number of benefits, including ten years of market exclusivity from product launch in the EU, fee reductions, and access to the

Dimension Therapeutics is focused on developing new adeno-associated virus (AAV) gene therapy treatments for rare diseases. Bayer HealthCare member of the Executive Committee and head of Global Drug

Roche and Genentech, a member of the Roche Group, develop and commercialize Erivedge under a deal with Curis, a US-based oncology-focused biotechnology firm. Curis president and chief executive

The expansion will add 50 patients to the original cohort of 56 patients to produce more robust results. The trial is enrolling non-metastatic prostate cancer patients who have

"We are very pleased to establish this strategic collaboration with TD2, as we see significant synergies between Inform Genomics’ proprietary technology and analytics along with TD2’s world-class oncology

miRagen and Servier Research will continue preclinical research and development on multiple cardiovascular programs targeting microRNAs, including miR-208 and miR-15. Servier will lead the global clinical development and